API Holdings absorbs Docon; 51.02% stake in Thyrocare vests in API

Acquisition announcedScheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹576.40

prior close

₹573.75

announcement price

After-mkt

timing

Nifty Microcap 250market+0.4%-0.5% vs market

Healthcare Service Provider peers, median of 27sector+0.2%-0.3% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.3 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.1

15m

-0.1

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+0.4-0.5+0.2-0.3

Next day

-1.0+0.9-1.9-0.6-0.4

-1.2+0.8-2.0-0.2-1.0

-3.2+0.6-3.8-0.4-2.8

-4.1+0.7-4.8-1.0-3.1

-4.9-2.6-2.3-1.9-3.0

-2.9-1.9-1.0-1.3-1.6

15d

-5.4-0.6-4.9-3.5-1.9

-11.0-1.0-10.0-4.9-6.1

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

API Holdings Ltd merged with its group company Docon Technologies, effective Sept 3, 2026, after NCLT approval on Aug 31. Docon's 51.02% stake (8,12,00,000 shares) in Thyrocare automatically vested in API Holdings by operation of law. No change in ultimate promoter holding of Thyrocare. Disclosed under Reg 10(6), exempted from open offer under Reg 10(1)(d)(iii).

Likely market impact

Internal group restructuring; Thyrocare's promoter control and shareholding pattern remain unchanged. No impact on minority shareholders.